Cancer as the disintegration of robustness: Population-level variance in gene expression identifies key differences between tobacco- and HPV-associated oropharyngeal carcinogenesis

Archives of Pathology and Laboratory Medicine

Volumn 139, Issue 11, 2015, Pages 1362-1372

  Ben Dayan, Miriam M ^a   MacCarthy, Thomas ^b   Schlecht, Nicolas F ^a   Belbin, Thomas J ^a   Childs, Geoffrey ^a   Smith, Richard V ^c   Prystowsky, Michael B ^a   Bergman, Aviv ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b Stony Brook University   (United States)

^c MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MODEL; CARCINOGENESIS; CELL TRANSFORMATION; COMPLICATION; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC VARIATION; GENETICS; HUMAN; NEOPLASMS; OROPHARYNX TUMOR; PAPILLOMAVIRUS INFECTION; RISK FACTOR; SMOKING; SQUAMOUS CELL CARCINOMA;

CARCINOGENESIS; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VARIATION; HUMANS; MODELS, GENETIC; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; SMOKING;

EID: 84945963807     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2014-0624-OA     Document Type: Article

References (62)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011; 61 (2): 69-90.
2. Jaber MA, Porter SR, Gilthorpe MS, Bedi R, Scully C. Risk factors for oral epithelial dysplasia-The role of smoking and alcohol. Oral Oncol. 1999; 35 (2): 151-156.
3. Pytynia KB, Dahlstrom KR, Sturgis EM. Epidemiology of HPV-Associated oropharyngeal cancer. Oral Oncol. 2014; 50 (5): 380-386.
4. Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: A systematic review. Cancer Epidemiol Biomarkers Prev. 2005; 14 (2): 467-475.
5. Vidal L, Gillison ML. Human papillomavirus in HNSCC: Recognition of a distinct disease type. Hematol Oncol Clin North Am. 2008; 22 (6): 1125-1142, vii.
6. Schlecht NF, Burk RD, Adrien L, et al. Gene expression profiles in HPVinfected head and neck cancer. J Pathol. 2007; 213 (3): 283-293.
7. Troy JD, Weissfeld JL, Youk AO, Thomas S, Wang L, Grandis JR. Expression of EGFR, VEGF, and NOTCH1 suggest differences in tumor angiogenesis in HPVpositive and HPV-negative head and neck squamous cell carcinoma. Head Neck Pathol. 2013; 7 (4): 344-355.
8. van Kempen PM, Noorlag R, Braunius WW, Stegeman I, Willems SM, Grolman W. Differences in methylation profiles between HPV-positive and HPVnegative oropharynx squamous cell carcinoma: A systematic review. Epigenetics. 2014; 9 (2): 194-203.
9. Lleras RA, Smith RV, Adrien LR, et al. Unique DNA methylation loci distinguish anatomic site and HPV status in head and neck squamous cell carcinoma. Clin Cancer Res. 2013; 19 (19): 5444-5455.
10. Lajer CB, Garnaes E, Friis-Hansen L, et al. The role of miRNAs in human papilloma virus (HPV) -Associated cancers: Bridging between HPV-related head and neck cancer and cervical cancer. Br J Cancer. 2012; 106 (9): 1526-1534.
11. Bol V, Gregoire V. Biological basis for increased sensitivity to radiation therapy in HPV-positive head and neck cancers. Biomed Res Int. 2014; 2014: 696028.
12. Mirghani H, Amen F, Blanchard P, et al. Treatment de-escalation in HPVpositive oropharyngeal carcinoma: Ongoing trials, critical issues and perspectives. Int J Cancer. 2015; 136 (7): 1494-1503.
13. Salazar CR, Anayannis N, Smith RV, et al. Combined P16 and human papillomavirus testing predicts head and neck cancer survival. Int J Cancer. 2014; 135 (10): 2404-2412.
14. Nygard M, Aagnes B, Bray F, Moller B, Mork J. Population-based evidence of increased survival in human papillomavirus-related head and neck cancer. Eur J Cancer. 2012; 48 (9): 1341-1346.
15. Sethi S, Ali-Fehmi R, Franceschi S, et al. Characteristics and survival of head and neck cancer by HPV status: A cancer registry-based study. Int J Cancer. 2012; 131 (5): 1179-1186.
16. Masel J, Siegal ML. Robustness: Mechanisms and consequences. Trends Genet. 2009; 25 (9): 395-403.
17. Waddington CH. Canalization of development and the inheritance of acquired characters. Nature. 1942 (150): 563-565.
18. Waddington CH. The Strategy of the Genes. London, England: Allen & Unwin; 1957.
19. Waddington CH. Evolutionary systems-Animal and human. Nature. 1959 (183): 1634-1638.
20. Siegal ML, Bergman A. Waddington's canalization revisited: Developmental stability and evolution. Proc Natl Acad Sci U S A. 2002; 99 (16): 10528-10532.
21. Bergman A, Siegal ML. Evolutionary capacitance as a general feature of complex gene networks. Nature. 2003; 424 (6948): 549-552.
22. Belbin TJ, Bergman A, Brandwein-Gensler M, et al. Head and neck cancer: Reduce and integrate for optimal outcome. Cytogenet Genome Res. 2007; 118 (2-4): 92-109.
23. Paaby AB, Rockman MV. Cryptic genetic variation: Evolution's hidden substrate. Nat Rev Genet. 2014; 15 (4): 247-258.
24. Gibson G, Dworkin I. Uncovering cryptic genetic variation. Nat Rev Genet. 2004; 5 (9): 681-690.
25. Hawley-Nelson P, Vousden KH, Hubbert NL, Lowy DR, Schiller JT. HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J. 1989; 8 (12): 3905-3910.
26. Paterlini-Brechot P, Saigo K, Murakami Y, et al. Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene. Oncogene. 2003; 22 (25): 3911-3916.
27. Price AM, Luftig MA. Dynamic Epstein-Barr virus gene expression on the path to B-cell transformation. Adv Virus Res. 2014; 88: 279-313.
28. Chen Y, Williams V, Filippova M, Filippov V, Duerksen-Hughes P. Viral carcinogenesis: Factors inducing DNA damage and virus integration. Cancers (Basel). 2014; 6 (4): 2155-2186.
29. Chen Z, Freitas LB, Burk RD. Evolution and classification of oncogenic human papillomavirus types and variants associated with cervical cancer. Methods Mol Biol. 2015; 1249: 3-26.
30. Leek JT, Johnson WE, Parker HS, Fertig EJ, Jaffe AE. Storey JD. sva: Surrogate Variable Analysis. R package version 3.12.0.
31. Sultan M, Piccini I, Balzereit D, et al. Gene expression variation in Down's syndrome mice allows prioritization of candidate genes. Genome Biol. 2007; 8 (5): R91.
32. Fang H, Gough J. supraHex: An R/Bioconductor package for tabular omics data analysis using a supra-hexagonal map. Biochem Biophys Res Commun. 2014; 443 (1): 285-289.
33. Langfelder P, Horvath S. WGCNA: An R package for weighted correlation network analysis. BMC Bioinformatics. 2008; 9: 559.
34. Zhang B, Horvath S. A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol. 2005; 4: Article17.
35. Hu Z, Mellor J, Wu J, DeLisi C. VisANT: An online visualization and analysis tool for biological interaction data. BMC Bioinformatics. 2004; 5: 17.
36. Thomas PD, Campbell MJ, Kejariwal A, et al. PANTHER: A library of protein families and subfamilies indexed by function. Genome Res. 2003; 13 (9): 2129-2141.
37. Harris T, Jimenez L, Kawachi N, et al. Low-level expression of miR-375 correlates with poor outcome and metastasis while altering the invasive properties of head and neck squamous cell carcinomas. Am J Pathol. 2012; 180 (3): 917-928.
38. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005; 120 (1): 15-20.
39. Murphree AL, Benedict WF. Retinoblastoma: Clues to human oncogenesis. Science. 1984; 223 (4640): 1028-1033.
40. Parada LF, Tabin CJ, Shih C, Weinberg RA. Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene. Nature. 1982; 297 (5866): 474-478.
41. Weinberg RA. Oncogenes and tumor suppressor genes. CA Cancer J Clin. 1994; 44 (3): 160-170.
42. Ksiazkiewicz M, Markiewicz A, Zaczek AJ. Epithelial-mesenchymal transition: A hallmark in metastasis formation linking circulating tumor cells and cancer stem cells. Pathobiology. 2012; 79 (4): 195-208.
43. Chen C, Zimmermann M, Tinhofer I, Kaufmann AM, Albers AE. Epithelialto-mesenchymal transition and cancer stem (-like) cells in head and neck squamous cell carcinoma. Cancer Lett. 2013; 338 (1): 47-56.
44. Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelialmesenchymal transition. Nat Rev Mol Cell Biol. 2014; 15 (3): 178-196.
45. Kaneko K. Characterization of stem cells and cancer cells on the basis of gene expression profile stability, plasticity, and robustness: Dynamical systems theory of gene expressions under cell-cell interaction explains mutational robustness of differentiated cells and suggests how cancer cells emerge. Bioessays. 2011; 33 (6): 403-413.
46. Tian T, Olson S, Whitacre JM, Harding A. The origins of cancer robustness and evolvability. Integr Biol. 2011; 3 (1): 17-30.
47. Masuda M, Toh S, Wakasaki T, Suzui M, Joe AK. Somatic evolution of head and neck cancer-biological robustness and latent vulnerability. Mol Oncol. 2013; 7 (1): 14-28.
48. Radisavljevic Z. AKT as locus of cancer positive feedback loops and extreme robustness. J Cell Physiol. 2013; 228 (3): 522-524.
49. Akagi K, Li J, Broutian TR, et al. Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability. Genome Res. 2014; 24 (2): 185-199.
50. Ashida H, Hong Y, Murakami Y, et al. Mammalian PIG-X and yeast Pbn1p are the essential components of glycosylphosphatidylinositol-mannosyltransferase I. Mol Biol Cell. 2005; 16 (3): 1439-1448.
51. Chatterjee S, Mayor S. The GPI-Anchor and protein sorting. Cell Mol Life Sci. 2001; 58 (14): 1969-1987.
52. Talukder AH, Meng Q, Kumar R. CRIPak, a novel endogenous Pak1 inhibitor. Oncogene. 2006; 25 (9): 1311-1319.
53. Teufel A, Wong EA, Mukhopadhyay M, Malik N, Westphal H. FoxP4, a novel forkhead transcription factor. Biochim Biophys Acta. 2003; 1627 (2-3): 147-152.
54. Rousso DL, Pearson CA, Gaber ZB, et al. Foxp-mediated suppression of Ncadherin regulates neuroepithelial character and progenitor maintenance in the CNS. Neuron. 2012; 74 (2): 314-330.
55. Hazan RB, Phillips GR, Qiao RF, Norton L, Aaronson SA. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol. 2000; 148 (4): 779-790.
56. Salazar C, Calvopina D, Punyadeera C. miRNAs in human papilloma virus associated oral and oropharyngeal squamous cell carcinomas. Expert Rev Mol Diagn. 2014; 14 (8): 1033-1040.
57. Kuhn DE, Martin MM, Feldman DS, Terry AV Jr, Nuovo GJ, Elton TS. Experimental validation of miRNA targets. Methods. 2008; 44 (1): 47-54.
58. Subramanyam D, Lamouille S, Judson RL, et al. Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells. Nat Biotechnol. 2011; 29 (5): 443-448.
59. Voellenkle C, Rooij J, Guffanti A, et al. Deep-sequencing of endothelial cells exposed to hypoxia reveals the complexity of known and novel microRNAs. RNA. 2012; 18 (3): 472-484.
60. Korkmaz G, le Sage C, Tekirdag KA, Agami R, Gozuacik D. miR-376b controls starvation and mTOR inhibition-related autophagy by targeting ATG4C and BECN1. Autophagy. 2012; 8 (2): 165-176.
61. Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015; 517 (7536): 576-582.
62. Parfenov M, Pedamallu CS, Gehlenborg N, et al. Characterization of HPV and host genome interactions in primary head and neck cancers. Proc Natl Acad Sci U S A. 2014; 111 (43): 15544-15549.